These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The contribution of thyroid dysfunction on cardiovascular disease in patients with chronic kidney disease. Tatar E; Kircelli F; Ok E Atherosclerosis; 2013 Mar; 227(1):26-31. PubMed ID: 23206977 [TBL] [Abstract][Full Text] [Related]
5. Most exposed: the endothelium in chronic kidney disease. Vila Cuenca M; Hordijk PL; Vervloet MG Nephrol Dial Transplant; 2020 Sep; 35(9):1478-1487. PubMed ID: 31071222 [TBL] [Abstract][Full Text] [Related]
6. Pediatric CKD and cardiovascular disease. Safder O; Al sharif S; Kari JA Cardiovasc Hematol Disord Drug Targets; 2014; 14(3):177-84. PubMed ID: 24720458 [TBL] [Abstract][Full Text] [Related]
7. Damage of the endothelial glycocalyx in chronic kidney disease. Padberg JS; Wiesinger A; di Marco GS; Reuter S; Grabner A; Kentrup D; Lukasz A; Oberleithner H; Pavenstädt H; Brand M; Kümpers P Atherosclerosis; 2014 Jun; 234(2):335-43. PubMed ID: 24727235 [TBL] [Abstract][Full Text] [Related]
8. Increased cardiovascular risk in patients with chronic kidney disease. Vondenhoff S; Schunk SJ; Noels H Herz; 2024 Mar; 49(2):95-104. PubMed ID: 38416185 [TBL] [Abstract][Full Text] [Related]
9. Progenitor cells and vascular function are impaired in patients with chronic kidney disease. Jie KE; Zaikova MA; Bergevoet MW; Westerweel PE; Rastmanesh M; Blankestijn PJ; Boer WH; Braam B; Verhaar MC Nephrol Dial Transplant; 2010 Jun; 25(6):1875-82. PubMed ID: 20083473 [TBL] [Abstract][Full Text] [Related]
10. Protecting the endothelium: a new focus for management of chronic kidney disease. Diaz-Buxo JA; Woods HF Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826 [TBL] [Abstract][Full Text] [Related]
11. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Xu S; Ilyas I; Little PJ; Li H; Kamato D; Zheng X; Luo S; Li Z; Liu P; Han J; Harding IC; Ebong EE; Cameron SJ; Stewart AG; Weng J Pharmacol Rev; 2021 Jul; 73(3):924-967. PubMed ID: 34088867 [TBL] [Abstract][Full Text] [Related]
12. The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise. Martens CR; Kirkman DL; Edwards DG Exerc Sport Sci Rev; 2016 Jan; 44(1):12-9. PubMed ID: 26509484 [TBL] [Abstract][Full Text] [Related]
13. Effect of Moderate Aerobic Exercise Training on Endothelial Function and Arterial Stiffness in CKD Stages 3-4: A Randomized Controlled Trial. Van Craenenbroeck AH; Van Craenenbroeck EM; Van Ackeren K; Vrints CJ; Conraads VM; Verpooten GA; Kouidi E; Couttenye MM Am J Kidney Dis; 2015 Aug; 66(2):285-96. PubMed ID: 25960303 [TBL] [Abstract][Full Text] [Related]
19. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514 [TBL] [Abstract][Full Text] [Related]
20. Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients. Ashokachakkaravarthy K; Rajappa M; Parameswaran S; Satheesh S; Priyadarshini G; Mohan Raj PS; Revathy G; Priyadarssini M Int Urol Nephrol; 2020 Jul; 52(7):1321-1328. PubMed ID: 32409974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]